# Oracea Soolantra Association in Participants With Severe Rosacea

> **NCT03075891** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 273 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** Ivermectin 1% cream
- **DRUG:** Doxycycline 40 mg MR (30 mg Immediate Release & 10 mg Delayed Release beads) capsules
- **OTHER:** Oral placebo capsules

## Key facts

- **NCT ID:** NCT03075891
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-05
- **Primary completion:** 2018-02-08
- **Final completion:** 2018-02-08
- **Target enrollment:** 273 (ACTUAL)
- **Last updated:** 2021-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03075891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03075891, "Oracea Soolantra Association in Participants With Severe Rosacea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03075891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*